1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

Area of Science:

• Endocrinology
• Cardiovascular Physiology
• Molecular Biology

Background:

• The renin-angiotensin system regulates blood pressure and fluid balance.
• Inappropriate activation is linked to hypertension, heart attack, and stroke.
• Clinical studies suggest an inverse link between vitamin D and blood pressure/renin activity, but mechanisms are unclear.

Purpose of the Study:

• To elucidate the mechanism by which vitamin D influences the renin-angiotensin system.
• To investigate the role of the vitamin D receptor (VDR) in regulating renin expression.
• To determine if vitamin D directly impacts renin transcription.

Main Methods:

• Utilized vitamin D receptor-null (VDR-null) mice to study renin expression and angiotensin II levels.
• Administered vitamin D (1,25(OH)2D3) to wild-type mice and inhibited its synthesis.
• Employed cell cultures to examine the direct effect of 1,25(OH)2D3 on renin gene transcription via VDR.

Main Results:

• VDR-null mice exhibited significantly increased renin expression, plasma angiotensin II, hypertension, and cardiac hypertrophy.
• Inhibition of 1,25(OH)2D3 synthesis in wild-type mice increased renin expression.
• 1,25(OH)2D3 administration suppressed renin expression, acting independently of calcium metabolism.
• 1,25(OH)2D3 suppressed renin transcription through a VDR-mediated pathway in cell cultures.

Conclusions:

• Vitamin D is a novel negative endocrine regulator of the renin-angiotensin system.
• The VDR mediates the suppressive effect of 1,25(OH)2D3 on renin expression.
• Vitamin D plays a crucial role in blood pressure and electrolyte homeostasis.
• Vitamin D analogues may offer a therapeutic strategy for preventing or treating hypertension.